Skip to main content
OpenTrials

Clinical trial discovery

Find Clinical Trials

Search studies by condition, treatment, location, eligibility, or trial identifier.

Showing 1–20 of 22 trials

Active filters

Clinical trials found

Published and searchable clinical trials

Searching for clinical trials...
Recruiting

Phase II Study of Trastuzumab Rezetecan or in Combination With Adebrelimab in HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC)

NCT07241793

Conditions
Advanced Urothelial Carcinoma, Carcinoma, Carcinoma, Transitional Cell, +5 more
Locations
  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Guangzhou, Guangdong, China
  • Sun yat-sen university cancer center Guangzhou, Guangdong, China
  • The fifth Affiliated Hospital of Guangzhou Medcial University Guangzhou, Guangdong, China
  • Tongji Hospital, Affiliated to Tongji Medical College of Huazhong University of Science and Technology Wuhan, Hubei, China
View Trial Details
Recruiting

A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma

NCT05929235

Conditions
Advanced Urothelial Carcinoma, Open Label, Oral Drug Administration
Locations
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Sylvester Comprehensive Cancer Center, University of Miami Miami, Florida, United States
  • The University of Chicago Medicine Chicago, Illinois, United States
View Trial Details
Recruiting

Probiotics in Advanced Urothelial Carcinoma

NCT06904573

Conditions
Advanced Urothelial Carcinoma, Immunotherapy, Probiotics
Locations
  • Sun yat-sen university cancer center Guangzhou, Guangdong, China
  • Sun Yat-sen Memorial Hospital Guangzhou, Guangdong, China
  • Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology Wuhan, Hubei, China
View Trial Details
Completed

Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer

NCT00942331

Conditions
Advanced Urothelial Carcinoma, Carcinoma, Carcinoma, Transitional Cell, +32 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Providence Hospital Mobile, Alabama, United States
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • University of Arizona Cancer Center-Orange Grove Campus Tucson, Arizona, United States
View all 873 locations
View Trial Details
Completed

Study to Evaluate Ibrutinib Combination Therapy in Patients With Selected Gastrointestinal and Genitourinary Tumors

NCT02599324

Conditions
Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Urothelial Carcinoma, +17 more
Locations
  • Clearview Cancer Institute /ID# 1128-0965 Huntsville, Alabama, United States
  • Banner MD Anderson Cancer Center /ID# 1128-0802 Gilbert, Arizona, United States
  • University of Arizona Cancer Center - Tucson /ID# 1128-1546 Tucson, Arizona, United States
  • Alta Bates Comprehensive Cancer Center /ID# 1128-0135 Berkeley, California, United States
View all 65 locations
View Trial Details
Active, Not Recruiting

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

NCT04491942

Conditions
Adenoma, Adnexal Diseases, Advanced Bile Duct Carcinoma, +72 more
Locations
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York, United States
View Trial Details
Active, Not Recruiting

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

NCT04514484

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Differentiated Thyroid Gland Carcinoma, +141 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Montefiore Medical Center-Einstein Campus The Bronx, New York, United States
  • University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations

NCT05544552

Conditions
Advanced Solid Tumor, Advanced Urothelial Carcinoma, Bladder Cancer, +31 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • UMass Memorial Medical Center Worchester, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center (MSKCC) New York, United States
  • Duke Cancer Institute (DCI) - Duke Cancer Center Durham, North Carolina, United States
View all 19 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate Safety, Efficacy of FF-10832 in Combo With Pembrolizumab in Urothelial & Non-small Cell Lung Cancer

NCT05318573

Conditions
Advanced Non Small Cell Lung Cancer, Advanced Urothelial Carcinoma
Locations
  • Cancer and Blood Speciality Clinic Long Beach, California, United States
  • Sharp Memorial Hospital (Oncology Clinical Research) San Diego, California, United States
  • Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • University of Kansas Cancer Center - Westwood Westwood, Kansas, United States
View all 23 locations
View Trial Details